Clinitiative Health Research

What Clinitiative Health Research does

Clinitiative Health Research operates a U.S. clinical trial site network that connects pharmaceutical sponsors and contract research organizations with a curated base of 50+ independent clinical research sites and 200+ principal investigators across 7+ U.S. states. Sites are admitted through a structured four-step participation process and operate under the company's ClinFirst™ governance standard, which enforces coordinated engagement protocols, structured milestone visibility, and built-in quality assurance. The network spans 14 active therapeutic specialties — including oncology, CNS, cardiovascular, immunology, rare disease, metabolic/obesity, and pulmonology — and covers Phase I through Phase IV studies, with active study volumes reported by therapeutic area.

The platform is built entirely in-house around three proprietary components: ClinFirst (sponsor-aligned governance), SiteScore (continuous quantitative evaluation of every network site on enrollment velocity, data quality, and compliance), and KOLScore (investigator influence and specialization framework for protocol-to-PI matching). AI and machine learning models — also proprietary and trained on de-identified data from 247 active sites contributing to quarterly benchmark calculations — power enrollment forecasting, site risk detection, protocol feasibility scoring, and investigator recommendations. The infrastructure is SOC 2 Type II aligned and HIPAA-compliant, with AES-256 and TLS 1.3 encryption, role-based access controls, and modular API integration into sponsor CTMS, EDC, and IWRS systems.

Revenue derives from three streams: subscription-style participation fees paid by sites admitted to the network, per-protocol feasibility assessment services delivered to sponsors and CROs (with a 6 business-day turnaround SLA), and ClinFirst governance and network-access subscriptions granted to sponsors engaging the network for trials. GTM is sales-led for sponsors, paired with a community-led motion for site acquisition; demand generation relies on direct sponsor outreach, a website-based protocol intake portal, and active exhibition at nine major industry conferences (SCRS, ACRP, MAGI, ASCO, BIO, WVC, SOCRA, Save Our Sites, Obesity Week) in 2026. The company is privately held, headquartered in Dallas, Texas, with 11–50 employees and no disclosed funding or revenue history.

Name

Clinitiative Health Research

Legal name

Clinitiative Health Research

Website

https://clinitiative.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Clinitiative Health Research operates a U.S. clinical trial site network of 50+ sites and 200+ principal investigators, providing pharmaceutical sponsors and CROs with AI-driven enrollment optimization, centralized ClinFirst governance, and SiteScore/KOLScore performance analytics across Phase I–IV studies and 14 therapeutic areas.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industries

Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI), Site & Investigator Platforms (Site Payments, Feasibility, Activation) (HLACAOAJ), Clinical CROs (Phase I–IV) (HLAGAAAA)

Keywords

• Clinical trial network
• Clinical research services
• Site management organization
• Sponsor feasibility assessment
• Investigator matching platform

Headquarters

HQ city

Dallas

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Network Site Participation Fees: Clinical trial sites pay to participate in the network after meeting ClinFirst governance standards and passing SiteScore evaluation. Participation is application-based and subject to performance alignment.
2. Feasibility Assessment Services: Sponsors and CROs submit protocol feasibility requests; the company delivers structured feasibility assessments within 6 business days, likely on a per-protocol fee basis.
3. ClinFirst Governance & Network Access: Sponsors gain access to the network of 50+ performance-managed sites, real-time performance dashboards, and centralized governance across their trial footprint in exchange for study engagement with the network.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

Clinitiative Health Research operates a performance-managed U.S. clinical trial site network of 50+ independent sites and 200+ principal investigators, governed by its proprietary ClinFirst™, SiteScore™, and KOLScore™ platforms. It delivers protocol feasibility assessments to pharmaceutical sponsors and CROs within 6 business days and continuously evaluates network sites using AI-driven analytics to standardize execution, reduce enrollment variability, and accelerate trial timelines across Phase I–IV studies and 15+ therapeutic areas.

Product overview

Clinitiative Health Research operates as a clinical trial site network platform with three proprietary technology systems working in concert. The core offering is the ClinFirst™ governance platform, which standardizes execution and reduces enrollment variability across the network. This is supported by SiteScore™ for continuous quantitative site evaluation and KOLScore™ for investigator intelligence. The platform integrates AI-driven analytics for enrollment forecasting, site matching, and risk detection, with secure data infrastructure that is SOC 2 aligned and HIPAA-compliant. All systems are built in-house, giving the company full control over capabilities and release cycles.

Differentiator

Problem solved

Functional benefit

Brands

• ClinFirst™: Sponsor-aligned governance standardizing execution and reducing enrollment variability across participating sites.
• SiteScore™
• KOLScore™

Products and services

• Clinical Trial Site Network A U.S. clinical research network of 50+ independent sites and 200+ principal investigators aligned to defined participation standards, performance benchmarks, and centralized ClinFirst™ governance, spanning 7+ U.S. states and Phase I–IV studies across 15+ therapeutic areas.
• ClinFirst™ Governance Platform Sponsor-aligned governance standard that standardizes execution and reduces enrollment variability across every participating site through coordinated engagement standards, structured milestone visibility, and built-in quality assurance protocols.
• SiteScore™ Engine Proprietary quantitative scoring engine that continuously evaluates every network site across enrollment performance, data quality, and compliance metrics, ensuring only high-performing sites remain active in the network portfolio.
• KOLScore™ Analytics Structured framework quantifying investigator influence, publication history, and therapeutic specialization to power investigator recommendations and support protocol-site matching decisions for sponsors.
• Protocol Feasibility Assessment Service Sponsors and CROs submit protocol documents (PDF, DOCX, or XLS up to 25 MB) through a centralized intake portal and receive a structured feasibility assessment within 6 business days, including site-matching and enrollment projections.
• Site Participation Program Application-based clinical research site membership that aligns independent sites to ClinFirst™ governance standards; sites complete a four-step review (application, 10-business-day initial review, SiteScore™ assessment, governance onboarding) to join the network.

Quantifiable outcome

• 50+ active sites across 7+ U.S. states with centralized governance and real-time performance tracking
• +4 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability4 records

Feature6 records

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Velocity Clinical Research: Large integrated, owned-and-operated clinical trial site network serving pharma sponsors and CROs across multiple therapeutic areas — the same site-network model Clinitiative operates, at greater scale.
• CenExel Clinical Research: Network of specialized clinical research sites and principal investigators running Phase I–IV trials for sponsors, directly comparable to Clinitiative's performance-managed site network.
• Javara: Integrated research organization embedding clinical trials into provider networks; competes for the same sponsor enrollment and site-coordination demand Clinitiative targets.
• Elligo Health Research: Technology-enabled clinical research site enablement and network company connecting sponsors to investigators and patients, closely aligned with Clinitiative's tech-plus-network approach.
• Headlands Research: Owned network of clinical trial sites focused on enrollment and diverse patient access for sponsors and CROs, mirroring Clinitiative's multi-site governance model.
• Centricity Research: Multi-site clinical research network running trials across therapeutic areas for sponsors, comparable to Clinitiative's network-scale execution offering.
• Flourish Research: Network of clinical research sites across cardiometabolic, CNS, and other areas serving sponsors and CROs, a direct site-network competitor.

Emerging players

• Care Access: Decentralized and site-based clinical research network using technology to accelerate enrollment, overlapping with Clinitiative's AI-driven site network model.
• Circuit Clinical: Integrated research organization and site network with a technology platform for trial matching and execution, similar to Clinitiative's combined network-and-software approach.

Others

• Florence Healthcare: Provides site enablement and clinical trial workflow software for research sites and sponsors; adjacent technology supplier rather than a competing site network, overlapping on the platform side of Clinitiative's offering.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/ClinitiativeHealthResearch
• LinkedInlinkedin.com/company/clinitiative

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clinitiative Health Research